001     176877
005     20240229133722.0
024 7 _ |a 10.1016/S2213-2600(21)00164-8
|2 doi
024 7 _ |a pmid:34411511
|2 pmid
024 7 _ |a pmc:PMC8410610
|2 pmc
024 7 _ |a 2213-2600
|2 ISSN
024 7 _ |a 2213-2619
|2 ISSN
024 7 _ |a altmetric:111907038
|2 altmetric
037 _ _ |a DKFZ-2021-02119
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a GBD 2019 Respiratory Tract Cancers Collaborators
|b 0
|e Collaboration Author
245 _ _ |a Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
260 _ _ |a Oxford
|c 2021
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1633940253_10605
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Prevention, control, and treatment of respiratory tract cancers are important steps towards achieving target 3.4 of the UN Sustainable Development Goals (SDGs)-a one-third reduction in premature mortality due to non-communicable diseases by 2030. We aimed to provide global, regional, and national estimates of the burden of tracheal, bronchus, and lung cancer and larynx cancer and their attributable risks from 1990 to 2019.Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 methodology, we evaluated the incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) of respiratory tract cancers (ie, tracheal, bronchus, and lung cancer and larynx cancer). Deaths from tracheal, bronchus, and lung cancer and larynx cancer attributable to each risk factor were estimated on the basis of risk exposure, relative risks, and the theoretical minimum risk exposure level input from 204 countries and territories, stratified by sex and Socio-demographic Index (SDI). Trends were estimated from 1990 to 2019, with an emphasis on the 2010-19 period.Globally, there were 2·26 million (95% uncertainty interval 2·07 to 2·45) new cases of tracheal, bronchus, and lung cancer, and 2·04 million (1·88 to 2·19) deaths and 45·9 million (42·3 to 49·3) DALYs due to tracheal, bronchus, and lung cancer in 2019. There were 209 000 (194 000 to 225 000) new cases of larynx cancer, and 123 000 (115 000 to 133 000) deaths and 3·26 million (3·03 to 3·51) DALYs due to larynx cancer globally in 2019. From 2010 to 2019, the number of new tracheal, bronchus, and lung cancer cases increased by 23·3% (12·9 to 33·6) globally and the number of larynx cancer cases increased by 24·7% (16·0 to 34·1) globally. Global age-standardised incidence rates of tracheal, bronchus, and lung cancer decreased by 7·4% (-16·8 to 1·6) and age-standardised incidence rates of larynx cancer decreased by 3·0% (-10·5 to 5·0) in males over the past decade; however, during the same period, age-standardised incidence rates in females increased by 0·9% (-8·2 to 10·2) for tracheal, bronchus, and lung cancer and decreased by 0·5% (-8·4 to 8·1) for larynx cancer. Furthermore, although age-standardised incidence and death rates declined in both sexes combined from 2010 to 2019 at the global level for tracheal, bronchus, lung and larynx cancers, some locations had rising rates, particularly those on the lower end of the SDI range. Smoking contributed to an estimated 64·2% (61·9-66·4) of all deaths from tracheal, bronchus, and lung cancer and 63·4% (56·3-69·3) of all deaths from larynx cancer in 2019. For males and for both sexes combined, smoking was the leading specific risk factor for age-standardised deaths from tracheal, bronchus, and lung cancer per 100 000 in all SDI quintiles and GBD regions in 2019. However, among females, household air pollution from solid fuels was the leading specific risk factor in the low SDI quintile and in three GBD regions (central, eastern, and western sub-Saharan Africa) in 2019.The numbers of incident cases and deaths from tracheal, bronchus, and lung cancer and larynx cancer increased globally during the past decade. Even more concerning, age-standardised incidence and death rates due to tracheal, bronchus, lung cancer and larynx cancer increased in some populations-namely, in the lower SDI quintiles and among females. Preventive measures such as smoking control interventions, air quality management programmes focused on major air pollution sources, and widespread access to clean energy should be prioritised in these settings.Bill & Melinda Gates Foundation.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 2 |a Global Burden of Disease: methods
|2 MeSH
650 _ 2 |a Global Burden of Disease: statistics & numerical data
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Incidence
|2 MeSH
650 _ 2 |a Respiratory Tract Neoplasms: epidemiology
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
650 _ 2 |a Socioeconomic Factors
|2 MeSH
700 1 _ |a Ebrahimi, Hedyeh
|b 1
700 1 _ |a Aryan, Zahra
|b 2
700 1 _ |a Saeedi Moghaddam, Sahar
|b 3
700 1 _ |a Bisignano, Catherine
|b 4
700 1 _ |a Rezaei, Shahabeddin
|b 5
700 1 _ |a Pishgar, Farhad
|b 6
700 1 _ |a Force, Lisa M
|b 7
700 1 _ |a Abolhassani, Hassan
|b 8
700 1 _ |a Abu-Gharbieh, Eman
|b 9
700 1 _ |a Advani, Shailesh M
|b 10
700 1 _ |a Ahmad, Sohail
|b 11
700 1 _ |a Alahdab, Fares
|b 12
700 1 _ |a Alipour, Vahid
|b 13
700 1 _ |a Aljunid, Syed Mohamed
|b 14
700 1 _ |a Amini, Saeed
|b 15
700 1 _ |a Ancuceanu, Robert
|b 16
700 1 _ |a Andrei, Catalina Liliana
|b 17
700 1 _ |a Andrei, Tudorel
|b 18
700 1 _ |a Arabloo, Jalal
|b 19
700 1 _ |a Arab-Zozani, Morteza
|b 20
700 1 _ |a Asaad, Malke
|b 21
700 1 _ |a Ausloos, Marcel
|b 22
700 1 _ |a Awedew, Atalel Fentahun
|b 23
700 1 _ |a Baig, Atif Amin
|b 24
700 1 _ |a Bijani, Ali
|b 25
700 1 _ |a Biondi, Antonio
|b 26
700 1 _ |a Bjørge, Tone
|b 27
700 1 _ |a Braithwaite, Dejana
|b 28
700 1 _ |a Brauer, Michael
|b 29
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 30
|u dkfz
700 1 _ |a Bustamante-Teixeira, Maria Teresa
|b 31
700 1 _ |a Butt, Zahid A
|b 32
700 1 _ |a Carreras, Giulia
|b 33
700 1 _ |a Castañeda-Orjuela, Carlos A
|b 34
700 1 _ |a Chimed-Ochir, Odgerel
|b 35
700 1 _ |a Chu, Dinh-Toi
|b 36
700 1 _ |a Chung, Michael T
|b 37
700 1 _ |a Cohen, Aaron J
|b 38
700 1 _ |a Compton, Kelly
|b 39
700 1 _ |a Dagnew, Baye
|b 40
700 1 _ |a Dai, Xiaochen
|b 41
700 1 _ |a Dandona, Lalit
|b 42
700 1 _ |a Dandona, Rakhi
|b 43
700 1 _ |a Dean, Frances E
|b 44
700 1 _ |a Derbew Molla, Meseret
|b 45
700 1 _ |a Desta, Abebaw Alemayehu
|b 46
700 1 _ |a Driscoll, Tim Robert
|b 47
700 1 _ |a Faraon, Emerito Jose A
|b 48
700 1 _ |a Faris, Pawan Sirwan
|b 49
700 1 _ |a Filip, Irina
|b 50
700 1 _ |a Fischer, Florian
|b 51
700 1 _ |a Fu, Weijia
|b 52
700 1 _ |a Gallus, Silvano
|b 53
700 1 _ |a Gebregiorgis, Birhan Gebresillassie
|b 54
700 1 _ |a Ghashghaee, Ahmad
|b 55
700 1 _ |a Golechha, Mahaveer
|b 56
700 1 _ |a Gonfa, Kebebe Bekele
|b 57
700 1 _ |a Gorini, Giuseppe
|b 58
700 1 _ |a Goulart, Bárbara Niegia Garcia
|b 59
700 1 _ |a Guerra, Maximiliano Ribeiro
|b 60
700 1 _ |a Hafezi-Nejad, Nima
|b 61
700 1 _ |a Hamidi, Samer
|b 62
700 1 _ |a Hay, Simon I
|b 63
700 1 _ |a Herteliu, Claudiu
|b 64
700 1 _ |a Hoang, Chi Linh
|b 65
700 1 _ |a Horita, Nobuyuki
|b 66
700 1 _ |a Hostiuc, Mihaela
|b 67
700 1 _ |a Househ, Mowafa
|b 68
700 1 _ |a Iavicoli, Ivo
|b 69
700 1 _ |a Ilic, Irena M
|b 70
700 1 _ |a Ilic, Milena D
|b 71
700 1 _ |a Irvani, Seyed Sina Naghibi
|b 72
700 1 _ |a Islami, Farhad
|b 73
700 1 _ |a Kamath, Ashwin
|b 74
700 1 _ |a Kaur, Supreet
|b 75
700 1 _ |a Khalilov, Rovshan
|b 76
700 1 _ |a Khan, Ejaz Ahmad
|b 77
700 1 _ |a Kocarnik, Jonathan M
|b 78
700 1 _ |a Kucuk Bicer, Burcu
|b 79
700 1 _ |a Kumar, G Anil
|b 80
700 1 _ |a La Vecchia, Carlo
|b 81
700 1 _ |a Lan, Qing
|b 82
700 1 _ |a Landires, Iván
|b 83
700 1 _ |a Lasrado, Savita
|b 84
700 1 _ |a Lauriola, Paolo
|b 85
700 1 _ |a Leong, Elvynna
|b 86
700 1 _ |a Li, Bingyu
|b 87
700 1 _ |a Lim, Stephen S
|b 88
700 1 _ |a Lopez, Alan D
|b 89
700 1 _ |a Majeed, Azeem
|b 90
700 1 _ |a Malekzadeh, Reza
|b 91
700 1 _ |a Manafi, Navid
|b 92
700 1 _ |a Menezes, Ritesh G
|b 93
700 1 _ |a Miazgowski, Tomasz
|b 94
700 1 _ |a Misra, Sanjeev
|b 95
700 1 _ |a Mohammadian-Hafshejani, Abdollah
|b 96
700 1 _ |a Mohammed, Shafiu
|b 97
700 1 _ |a Mokdad, Ali H
|b 98
700 1 _ |a Molassiotis, Alex
|b 99
700 1 _ |a Monasta, Lorenzo
|b 100
700 1 _ |a Moradzadeh, Rahmatollah
|b 101
700 1 _ |a Morawska, Lidia
|b 102
700 1 _ |a Morgado-da-Costa, Joana
|b 103
700 1 _ |a Morrison, Shane Douglas
|b 104
700 1 _ |a Naimzada, Mukhammad David
|b 105
700 1 _ |a Nazari, Javad
|b 106
700 1 _ |a Nguyen, Cuong Tat
|b 107
700 1 _ |a Nguyen, Huong Lan Thi
|b 108
700 1 _ |a Nikbakhsh, Rajan
|b 109
700 1 _ |a Nuñez-Samudio, Virginia
|b 110
700 1 _ |a Olagunju, Andrew T
|b 111
700 1 _ |a Otstavnov, Nikita
|b 112
700 1 _ |a Otstavnov, Stanislav S
|b 113
700 1 _ |a P A, Mahesh
|b 114
700 1 _ |a Pana, Adrian
|b 115
700 1 _ |a Park, Eun-Kee
|b 116
700 1 _ |a Pottoo, Faheem Hyder
|b 117
700 1 _ |a Pourshams, Akram
|b 118
700 1 _ |a Rabiee, Mohammad
|b 119
700 1 _ |a Rabiee, Navid
|b 120
700 1 _ |a Radfar, Amir
|b 121
700 1 _ |a Rafiei, Alireza
|b 122
700 1 _ |a Rahman, Muhammad Aziz
|b 123
700 1 _ |a Ram, Pradhum
|b 124
700 1 _ |a Rathi, Priya
|b 125
700 1 _ |a Rawaf, David Laith
|b 126
700 1 _ |a Rawaf, Salman
|b 127
700 1 _ |a Rezaei, Nima
|b 128
700 1 _ |a Roberts, Nicholas L S
|b 129
700 1 _ |a Roberts, Thomas J
|b 130
700 1 _ |a Ronfani, Luca
|b 131
700 1 _ |a Roshandel, Gholamreza
|b 132
700 1 _ |a Samy, Abdallah M
|b 133
700 1 _ |a Santric-Milicevic, Milena M
|b 134
700 1 _ |a Sathian, Brijesh
|b 135
700 1 _ |a Schneider, Ione Jayce Ceola
|b 136
700 1 _ |a Sekerija, Mario
|b 137
700 1 _ |a Sepanlou, Sadaf G
|b 138
700 1 _ |a Sha, Feng
|b 139
700 1 _ |a Shaikh, Masood Ali
|b 140
700 1 _ |a Sharma, Rajesh
|b 141
700 1 _ |a Sheikh, Aziz
|b 142
700 1 _ |a Sheikhbahaei, Sara
|b 143
700 1 _ |a Siddappa Malleshappa, Sudeep K
|b 144
700 1 _ |a Singh, Jasvinder A
|b 145
700 1 _ |a Sitas, Freddy
|b 146
700 1 _ |a Spurlock, Emma Elizabeth
|b 147
700 1 _ |a Steiropoulos, Paschalis
|b 148
700 1 _ |a Tabarés-Seisdedos, Rafael
|b 149
700 1 _ |a Tadesse, Eyayou Girma
|b 150
700 1 _ |a Takahashi, Ken
|b 151
700 1 _ |a Traini, Eugenio
|b 152
700 1 _ |a Tran, Bach Xuan
|b 153
700 1 _ |a Tran, Khanh Bao
|b 154
700 1 _ |a Travillian, Ravensara S
|b 155
700 1 _ |a Vacante, Marco
|b 156
700 1 _ |a Villeneuve, Paul J
|b 157
700 1 _ |a Violante, Francesco S
|b 158
700 1 _ |a Yousefi, Zabihollah
|b 159
700 1 _ |a Yuce, Deniz
|b 160
700 1 _ |a Zadnik, Vesna
|b 161
700 1 _ |a Zamanian, Maryam
|b 162
700 1 _ |a Zendehdel, Kazem
|b 163
700 1 _ |a Zhang, Jianrong
|b 164
700 1 _ |a Zhang, Zhi-Jiang
|b 165
700 1 _ |a Farzadfar, Farshad
|b 166
700 1 _ |a Murray, Christopher J L
|b 167
700 1 _ |a Naghavi, Mohsen
|b 168
773 _ _ |a 10.1016/S2213-2600(21)00164-8
|g Vol. 9, no. 9, p. 1030 - 1049
|0 PERI:(DE-600)2704917-6
|n 9
|p 1030 - 1049
|t The lancet / Respiratory medicine
|v 9
|y 2021
|x 2213-2600
909 C O |o oai:inrepo02.dkfz.de:176877
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-03
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LANCET RESP MED : 2019
|d 2021-02-03
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b LANCET RESP MED : 2019
|d 2021-02-03
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21